Literature DB >> 35439570

Modulating tumor physical microenvironment for fueling CAR-T cell therapy.

Zhong Luo1, Xuemei Yao1, Menghuan Li1, Yang Fei1, Zhuo Cheng1, Yingying Xu2, Bo Zhu3.   

Abstract

Chimeric antigen receptor (CAR) T cell therapy has achieved unprecedented clinical success against hematologic malignancies. However, the transition of CAR-T cell therapies for solid tumors is limited by heterogenous antigen expression, immunosuppressive microenvironment (TME), immune adaptation of tumor cells and impeded CAR-T-cell infiltration/transportation. Recent studies increasingly reveal that tumor physical microenvironment could affect various aspects of tumor biology and impose profound impacts on the antitumor efficacy of CAR-T therapy. In this review, we discuss the critical roles of four physical cues in solid tumors for regulating the immune responses of CAR-T cells, which include solid stress, interstitial fluid pressure, stiffness and microarchitecture. We highlight new strategies exploiting these features to enhance the therapeutic potency of CAR-T cells in solid tumors by correlating with the state-of-the-art technologies in this field. A perspective on the future directions for developing new CAR-T therapies for solid tumor treatment is also provided.
Copyright © 2022 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biochemical and physical modulation; CAR-T cell therapy; Immunosuppression; Tumor physical microenvironment

Mesh:

Substances:

Year:  2022        PMID: 35439570     DOI: 10.1016/j.addr.2022.114301

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  2 in total

1.  Spermidine Promotes Nb CAR-T Mediated Cytotoxicity to Lymphoma Cells Through Elevating Proliferation and Memory.

Authors:  Hongxia Wang; Dan Jiang; Liyuan Liu; Yanting Zhang; Miao Qin; Yuliang Qu; Liyan Wang; Shan Wu; Haijin Zhou; Tao Xu; Guangxian Xu
Journal:  Onco Targets Ther       Date:  2022-10-18       Impact factor: 4.345

2.  Chimeric Oncolytic Adenovirus Armed Chemokine Rantes for Treatment of Breast Cancer.

Authors:  Lin Ang; Jiang Li; Hui Dong; Chunhong Wang; Jin Huang; Mingcong Li; Min Zhao; Changqing Su; Qiang Wu
Journal:  Bioengineering (Basel)       Date:  2022-07-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.